Publication date: November 2026 Source: European Urology Open Science, Volume 93 Author(s): Mathijs P. Scholtes, Esmee Koedoot, Lieke J. Ceton, Timothy J.P. Sijsenaar, Marta G. Montero, Caithlyn Z. Roeland, Robert J. van Soest, Joost Leijte, Hossein Roshani, Ruben Korthorst, Dieudonné J. van der Meer, Geert J.L.H. van Leenders, Willemijn Vader, Joost L. Boormans, Tahlita C.M. Zuiverloon
Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer. // European Urology Open Science. – URL: https://www.sciencedirect.com/science/article/pii/S2666168326006671?dgcid=rss_sd_all
Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer. European Urology Open Science. https://www.sciencedirect.com/science/article/pii/S2666168326006671?dgcid=rss_sd_all
“Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer.” European Urology Open Science.
@article{article45598,
title = {Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer},
journal = {European Urology Open Science},
url = {https://www.sciencedirect.com/science/article/pii/S2666168326006671?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...